Investors Are Paying the Price as Drugmakers Flood Bond Market

(Bloomberg) -- Drug companies that have rushed to borrow in the bond market this year are finding out that their actions have consequences for investors.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.